FDA moving towards authorizing second omicron booster, WSJ reports

The Food and Drug Administration is closing in on a decision whether to authorize a second round of the omicron-targeted booster shots for the elderly and other people at high-risk of severe COVID-19, Stephanie Armour and Liz Essley Whyte of Wall Street Journal report, citing people familiar with the agency’s deliberations. The FDA is moving toward authorizing the omicron-targeted shots for people who are 65 years and older or who have weakened immune systems, though the officials haven’t reached a final decision and could change their mind, a source told the Journal. Reference Link